• Home
  • Stock
  • Bliss GVS Pharma Fundamental Analysis
  • Bliss GVS Pharma Fundamental Analysis

Bliss GVS Pharma fundamental analysis

BLISSGVS

HealthcareSmall

160.73

5.18 (-3.12%)
Last updated on 19 Nov, 2025 | 15:55 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Bliss GVS Pharma Fundamentals

P/E Ratio

16.08

P/B Ratio

1.56

Div. Yield

0.3

Sector P/E

37.9

Sector P/B

3.65

Sec. Div. Yield

0.57

  • Bliss GVS Pharma Fundamentals is currently trading with a P/E Ratio of 16.08, compared to the sector average of 37.9. Its P/B Ratio stands at 1.56, while the sector’s is 3.65. In terms of returns, the stock offers a Dividend Yield of 0.3%, which is than the sector’s 0.57%.

Bliss GVS Pharma Score Card

  • Price

    Attractive

  • Growth

    Average

  • Quality

    Good

  • Management

    Average

  • On its scorecard, Bliss GVS Pharma reflects: Price – Attractive, Growth – Average, Quality – Good, and Management – Average. Together, these indicators provide a structured view of the company’s fundamentals.